← Back to Explore

Identification of Pancreatic Cancer Driver Genes with Machine Learning

JSHS · 2022

Overview

With the lowest 5-year survival rate (9%) among all types of cancer, pancreatic cancer is considered one of the most lethal diseases in the world. Current conventional treatments often fail because there are no reliable genes to target in pancreatic cancer therapies and drugs. Hence, there is a crucial need for the discovery of new pancreatic cancer driver genes for the development of better treatments. This study develops a state-of-the- art machine learning workflow for identifying key driver genes for pancreatic cancer. Our workflow identifies several genes, including KRT17, S100A4, and PTGS2, which have high potential as targets for pancreatic cancer therapies and have been validated with over hundreds of publications in literature. Our workflow also identifies novel genes, including SSFA2 and NDUFA6, that have never been studied before while showing great potential as therapy targets. These new genes provide directions for further experimental studies for advancing pancreatic cancer treatments.

Competition history

  • JSHS 2022 Category not listed

Resources

Related projects

Closest projects by meaning, across every fair and year in the corpus.

Source: Junior Science and Humanities Symposium

Save projects to your library

Sign in with Google to keep track of projects you find interesting, organized into folders. An account also raises your daily allowance for “Has this been done?”, and lets you create a key for the MCP server with a much higher limit than anonymous use. Browsing stays public.

Continue with Google